heart faliure
Conditions
Interventions
experimental group:Home-based Cardiac Exercise Rehabilitation with Remote Electrocardiogram Monitoring
Control group:Conventional Rehabilitation
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Aged 18-75 years old, male or female; (2) chronic heart failure (NYHA classification I-III); LVEF<50% in 6 weeks before randomization; (3) in stable condition after heart failure standard drug therapy(do not need intravenous diuretics, vasoconstrictors, vasodilators or left ventricular assist device),no fluid retention,constant weight; (4) able to perform exercise rehabilitation; (5) clearly understand the content and purpose of the study and volunteer to participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. exercise rehabilitation can not be carried out due to physical disability and contraindication; 2. with a contraindication to cardiopulmonary exercise test; 3. the following was happened in 3 months before admission: acute coronary syndrome, stroke, transient ischemic attack;cardiac,carotid artery or other major vascular surgery;percutaneous coronary intervention (PCI)or carotid artery angioplasty;sustained ventricular tachycardia or fibrillation; 4. coronary revascularization or heart transplantation is planned; 5. ventricular arrhythmias were not effectively controlled (using an antiarrhythmic drug or an implantable defibrillator); 6. uncorrected primary obstructive or severe regurgitant heart valve disease,restrictive or hypertrophic cardiomyopathy; 7. II or III degree heart block or sick sinus syndrome without permanent pacemaker implantation; need implantable device therapy for heart failure; 8. obstructive or bronchospasm lung disease(such as asthma, bronchitis,etc) needing oral or inhaled bronchodilator or glucocorticoids therapy; 9. pregnant or lactating women and those planning to conceive during the trial; 10. cancer or other systemic diseases with an expected survival of less than 12 months; 11. other clinical trial drugs were taken or in other medical device trial within 30 days before admission; 12. unable to participate in this study after the clinical evaluation by investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VO2Peak; | — |
Secondary
| Measure | Time frame |
|---|---|
| 6 minute walk distance;left ventricular ejection fraction; | — |
Countries
China
Contacts
Public ContactLi Xianlun
China-Japan Friendship Hospital
Outcome results
None listed